Clinical Trial Update: Evaluation of Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korea

View source ↗

Summary

A completed Korea-based clinical trial evaluated the safety and efficacy of botulinum toxin type A (BOTOX) for urinary incontinence due to neurogenic detrusor o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Detrusor Overactivity
• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Allergan | Conditions: Urinary Incontinence, Urinary Bladder, Overactive | Status: COMPLETED